Shilpa Grover

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

Alimentary pharmacology & therapeutics

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Inflammatory bowel diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew J Townsend, Isaac J Benque, Michael Li, Shilpa Grover
Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors. Alimentary pharmacology & therapeutics (2024)
Matthew J Townsend, Isaac J Benque, Michael Li, Shilpa Grover
Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors. Alimentary pharmacology & therapeutics 59 (11) (2024)
Matthew J Townsend, Isaac J Benque, Michael Li, Shilpa Grover
Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors. Alimentary pharmacology & therapeutics 59 (11) (2024)
Virginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, Vineet K Raghu, Chia-Yun Wu, Leyre Zubiri, Azin Ghamari, Nicole R LeBoeuf, Osama Abu-Shawer, Kenneth L Kehl, Shilpa Grover, Prabhsimranjot Singh, Giselle Alexandra Suero-Abreu, Jessica Wu, Ayo S Falade, Kelley Grealish, Molly F Thomas, Nora Hathaway, Benjamin D Medoff, Hannah K Gilman, Alexandra-Chloé Villani, Jor Sam Ho, Meghan J Mooradian, Meghan E Sise, Daniel A Zlotoff, Steven M Blum, Michael L Dougan, Ryan J Sullivan, Tomas G Neilan, Kerry Lynn Reynolds
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew J Townsend, Isaac J Benque, Michael Li, Shilpa Grover
Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors. Alimentary pharmacology & therapeutics 59 (11) (2024)
Lawrence Kogan, Matthew J Townsend, Dhanya Raj, Alexander N Levy, Anita Giobbie-Hurder, Shilpa Grover
Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study. Inflammatory bowel diseases (2023)
Aneesha Haryal, Matthew J Townsend, Vinitha Baskaran, Padmavathi Srivoleti, Anita Giobbie-Hurder, Jordan S Sack, Raymond A Isidro, Nicole R LeBoeuf, Elizabeth I Buchbinder, F Stephen Hodi, Shilpa Grover
Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course. Cancer (2022)
Shilpa Grover, Sheila A Bond, Michael K Mansour, Sonia Friedman
Management of immunotherapy colitis: Special considerations in the COVID-19 era. Cancer 126 (21) (2020)
Michael Li, Jordan S Sack, Osama E Rahma, F Stephen Hodi, Stephen D Zucker, Shilpa Grover
Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis. Cancer 126 (23) (2020)
Shilpa Grover, Amitabh Srivastava
Lymphocytic colitis-like pattern of mucosal injury and the challenges in diagnosing cancer immunotherapy-related toxicity. Cancer 125 (11) (2019)